Xenon Pharmaceuticals Inc.

Healthcare · Biotechnology · Canada

Last price 37.41 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 3.62B

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders. Its product candidates include Azetukalner, a novel, potent Kv7 potassium channel opener which is in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. In a...